Active management of third stage of labour: a comparative study of intra-umbilical oxytocin versus intramuscular oxytocin

Neerja Gupta; Manjushree Athokpam

doi:10.18203/2320-1770.ijrcog20173458

Authors

Neerja Gupta Department of Obstetrics and Gynecology, Muzaffar Nagar Medical College, Muzaffarnagar, Uttar Pradesh, India
Manjushree Athokpam Department of Obstetrics and Gynecology, Muzaffar Nagar Medical College, Muzaffarnagar, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20173458

Keywords:

Active management of 3rd stage of labour, Caesarian section, Post partum haemorrhage

Abstract

Background: Postpartum haemorrhage is a single major and leading cause of maternal morbidity and mortality, not only in the developing countries but also in developed countries. Every 4 minutes one woman dies from pregnancy or child birth related complications. The present study is to compare oxytocin used via intra-umbilical or intramuscular route in the active management of third stage of labour with respect to duration and amount of bleeding.

Methods: Four hundred pregnant women at term of a singleton pregnancy with spontaneous onset of labour were included in the study and were randomly divided into 2 groups of 200 women each. Group 1, intra-umbilical oxytocin 10U diluted in 10ml of saline, and Group 2, intramuscular oxytocin 10U were given after the delivery of baby.

Results: The outcome criteria with respect to third stage of labour were: duration of the 3^rd stage of labour, blood loss by volume, difference in haemoglobin. A significant reduction in duration of third stage (p = 0.001) and blood loss in third stage (p =0.0001) in intra-umbilical oxytocin group was found when compared with intramuscular oxytocin use.

Conclusions: Intra-umbilical oxytocin is better alternative to intramuscular oxytocin in active management of third stage of labour.

Metrics

Metrics Loading ...

References

Ministry health and family welfare, Press release;2015.

Mukherjee J, Ganguli RP, Saha SR, Maternal Mortality due to haemorrhage with emphasis on PPH. J Obstet Gynecol India. 2001;57(5):130-3.

Chamberlain G. The clinical aspects of massive haemorrhage. Maternal Mortality-The Way forward London: RCOG. 1992:54-62.

Cunningham G, Leveno KJ, Bloom SL, Hauth JC, Gilstrap LC, Wenstrom KD. William's Obstetrics, 23nd ed. McGraw-Hill Professional, Philadelphia. 2010:310-35.

Organization WHO. WHO recommendations for the prevention of postpartum haemorrhage. Geneva: World Health Organization: Department of Making Pregnancy Safer; 2007.

Dahiya P, Puri M, Rathee S. Influence of intraumbilical oxytocin on the third stage of labour. Ind J Medic Sci. 1995;49(2):23.

Kore S, Srikrishna S, Hedge A, AmbiyeVR VP. Active management of third stage of labour with intraumbilical oxytocin injection. J Obstet Gynecol India. 2000;50(3):54-5.

Shrestha P, Babu CS. Influence of umbilical vein oxytocin on blood loss and length of third stage of labour. Nepal Med Coll J; 2007.

Ojha N, Malla DS. Active management of third stage of labour by oxytocin: Umbilical vein versus intramuscular use. N J Obstet Gynecol. 20074;2(1):13-6.

Manhas A, Habib H. A randomized controlled study of prophylactic use of umbilical vein oxytocin in the management of third stage of labor. IOSR-JDMS. 2012;1(6):27-30.